Search Results 251-260 of 17029 for pharmacogenetics
Primary biliary cholangitis and primary sclerosing cholangitis are rare chronic and progressive cholestatic liver diseases that contribute to hepatic failure ...
Find research published by Mayo Clinic clinicians and investigators to share their expertise related to individualized or personalized medicine.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
The purpose of this study is to identify common genetic variants contributing to the risk of glioma. Evaluate gene-gene and gene-environmental interactions with ...
The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy. Genes. 2023; doi:10.3390/genes14051095. Henssler J, et al ...
Collaborators. Dr. Lazaridis is involved in several research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators.
Cancer initiates from genetic alterations, including mutations, deletions and copy number gains, that function to activate cancer-promoting pathways or to block ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.